Introduction
Patients and methods
Patient extraction
Selection of molecules for factor analysis
Category | Molecules | Number of papers by multivariate (M) or univariate (U) analysis |
---|---|---|
Oncogene | k-ras
| |
c-myc
| ||
Tumor suppressor gene |
p53
| (M-8a, U-13b) |
DCC
| ||
p27
| ||
RUNX3
| ||
MSI (MMR gene) | MSI/BAT | (M-3, U-3) |
Cell proliferation | Cyclin D1 | |
PCNA | (M-4) | |
MIB-1 | ||
Ki-67 | ||
Growth factor/cytokine and those receptor | EGF/erbB2 | (M-15, U-20) |
VEGF | (M-12, U-6) | |
c-met | (M-6) | |
TGF-b/Smad | (M-6) | |
b-FGF | (U-2) | |
PDGF | ||
TGF-α | ||
IL-6 | ||
IL-18 | ||
CCR7 | ||
TNFR | ||
Apoptosis signal pathway | Bcl-2 | (U-2) |
Bax | ||
Caspase 3 | ||
NF kappa B | ||
Cell invasion and adhesion | TIMP | (M-4) |
uPA | (M-3, U-2) | |
E-cadherin | (M-3, U-2) | |
CD4 | (U-2) | |
MMPs | ||
PAI-1, 2 | ||
AMF | ||
KISS-1 | ||
Angiogenesis | Thymidine phosphorylase | (U-4) |
Others | COX2 | (M-2, U-2) |
Microvessel count | (U-4) | |
Metastatic LN ration |
Immunohistochemical staining and evaluation
Data and statistical analysis
Results
Expression of various molecules as evaluated by immunostaining
Correlation of postoperative recurrence and clinicopathological factors or the expression of the candidate molecular factors
Clinicopathological factors and G-factors expression | Recurrence |
p value | |
---|---|---|---|
Negative
n = 106 (50 %) | Positive
n = 104 (50 %) | ||
Gender | |||
Male | 76 (50 %) | 72 (50 %) | 1.000 |
Female | 30 (50 %) | 32 (50 %) | |
Location | |||
U | 24 (41 %) | 30 (59 %) | 0.290 |
M | 47 (54 %) | 42 (46 %) | |
L | 35 (51 %) | 32 (49 %) | |
pT | |||
1 | 8 (69 %) | 1 (31 %) | 0.008 |
2 | 51 (59 %) | 35 (41 %) | |
3 | 47 (43 %) | 63 (57 %) | |
4 | 0 (0 %) | 5 (100 %) | |
pN | |||
Negative | 26 (64 %) | 10 (36 %) | 0.078 |
Positive | 80 (47 %) | 94 (53 %) | |
pN | |||
0 | 26 (64 %) | 10 (36 %) | 0.041 |
1 | 55 (53 %) | 48 (47 %) | |
2 | 24 (36 %) | 45 (64 %) | |
3 | 1 (50 %) | 1 (50 %) | |
Stage | |||
II | 76 (73 %) | 28 (27 %) | <0.001 |
III | 30 (28 %) | 76 (71 %) | |
Histologic type | |||
Diffuse type | 64 (51 %) | 62 (49 %) | 0.911 |
Intestinal type | 42 (50 %) | 42 (50 %) | |
Lymphatic invasion | |||
Negative | 32 (69 %) | 10 (31 %) | 0.002 |
Positive | 74 (45 %) | 94 (55 %) | |
Venous invasion | |||
Negative | 76 (64 %) | 40 (36 %) | <0.001 |
Positive | 30 (32 %) | 64 (68 %) | |
p53 | |||
Negative | 67 (55 %) | 56 (45 %) | 0.100 |
Positive | 39 (43 %) | 48 (57 %) | |
VEGF-A | |||
Negative | 55 (56 %) | 40 (44 %) | 0.105 |
Positive | 51 (45 %) | 64 (55 %) | |
VEGF-C | |||
Negative | 28 (48 %) | 28 (52 %) | 0.651 |
Positive | 78 (51 %) | 76 (49 %) | |
Reg IV | |||
Negative | 76 (49 %) | 80 (51 %) | 0.536 |
Positive | 30 (54 %) | 24 (46 %) | |
Olfactomedin 4 | |||
Negative | 30 (42 %) | 41 (58 %) | 0.089 |
Positive | 76 (54 %) | 63 (46 %) | |
Claudin-18 | |||
Negative | 37 (47 %) | 39 (53 %) | 0.485 |
Positive | 69 (52 %) | 45 (48 %) | |
MMP-7 | |||
Negative | 64 (56 %) | 48 (44 %) | 0.058 |
Positive | 42 (43 %) | 56 (57 %) | |
HER2 | |||
Negative | 87 (48 %) | 96 (52 %) | 0.073 |
Positive | 19 (66 %) | 8 (34 %) |
Prognostic analysis of OS and DFS in expression of the candidate molecular factors
Feasibility of the candidate factors for G-factor
Variable | OS univariate analysis | OS multivariate analysis | DFS univariate analysis | DFS multivariate analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95 % CI |
p value | HR | 95 % CI |
p value | HR | 95 % CI |
p value | HR | 95 % CI |
p value | |
p53/MMP-7 expression | ||||||||||||
G2 vs. G0/1 | 1.83 | 1.15–2.90 | 0.010 | 1.59 | 0.99–2.55 | 0.052 | 2.15 | 1.26–3.68 | 0.005 | 1.90 | 1.10–3.30 | 0.022 |
Depth of invasion | ||||||||||||
T1, T2 vs. T3, T4 | 1.99 | 1.39–2.87 | <0.001 | 2.40 | 1.65–3.51 | <0.001 | 1.79 | 1.20–2.70 | 0.005 | 2.17 | 1.43–3.30 | <0.001 |
Lymph node metastasis | ||||||||||||
Positive vs. negative | 2.61 | 1.22–4.82 | 0.011 | 3.68 | 1.75–7.70 | 0.001 | 2.86 | 1.32–6.21 | 0.008 | 4.33 | 1.85–10.15 | 0.001 |
Lymphatic invasion | ||||||||||||
Positive vs. negative | 2.61 | 1.36–5.03 | 0.004 | 1.89 | 0.95–3.76 | 0.068 | 4.41 | 1.79–10.91 | 0.001 | 2.92 | 1.15–7.41 | 0.024 |
Venous invasion | ||||||||||||
Positive vs. negative | 2.56 | 1.70–3.85 | <0.001 | 1.90 | 1.23–2.93 | 0.004 | 2.77 | 1.77–4.34 | <0.001 | 1.94 | 1.21–3.11 | 0.06 |